This year’s winners also include the developers of nusinersen, an oligonucleotide therapeutic for spinal muscular atrophy.

A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.

Macrophages play numerous roles within tumors, leaving cancer researchers with a choice: eliminate the cells or recruit them.

Researchers explore how blood platelets sweep bacteria into aggregate bundles at sites of infection to help phagocytic cells dispose of them.